Volume 72, Issue 3, Pages (August 2007)

Slides:



Advertisements
Similar presentations
Volume 65, Issue 1, Pages (January 2004)
Advertisements

Increased expression of heparanase in overt diabetic nephropathy
Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-α produced by renal parenchymal cells  B. Zhang, G. Ramesh, C.C. Norbury, W.B. Reeves 
Volume 80, Issue 2, Pages (July 2011)
Volume 72, Issue 10, Pages (November 2007)
Volume 56, Pages S54-S56 (July 1999)
Gluten and IgA nephropathy: you are what you eat?
Volume 79, Issue 4, Pages (February 2011)
Volume 76, Issue 5, Pages (September 2009)
Volume 65, Issue 1, Pages (January 2004)
Volume 69, Issue 10, Pages (May 2006)
Volume 72, Issue 7, Pages (October 2007)
Volume 80, Issue 9, Pages (November 2011)
Volume 62, Issue 6, Pages (December 2002)
Volume 63, Issue 1, Pages (January 2003)
Volume 63, Issue 6, Pages (June 2003)
Relaxin in cardiovascular and renal disease
Volume 70, Issue 7, Pages (October 2006)
Volume 69, Issue 1, Pages (January 2006)
Peritubular capillaritis in the renal allograft takes center stage
Volume 84, Issue 5, Pages (November 2013)
T helper17 Cells Are Sufficient But Not Necessary to Induce Acute Graft-Versus-Host Disease  Cristina Iclozan, Yu Yu, Chen Liu, Yaming Liang, Tangsheng.
Volume 71, Issue 8, Pages (April 2007)
Distinct phases in recovery of reconstituted innate cellular-mediated immunity after murine syngeneic bone marrow transplantation  Jeffery J. Auletta,
A new mouse model of immune-mediated podocyte injury
Volume 81, Issue 9, Pages (May 2012)
Yang Wang, Yi Ping Wang, Yuet-Ching Tay, David C.H. Harris 
Volume 80, Issue 12, Pages (December 2011)
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Molecular Therapy - Nucleic Acids
Volume 70, Issue 3, Pages (August 2006)
Volume 73, Issue 7, Pages (April 2008)
Volume 66, Issue 3, Pages (September 2004)
Volume 71, Issue 4, Pages (February 2007)
Volume 70, Issue 2, Pages (July 2006)
Stephen R. Holdsworth, A. Richard Kitching, Peter G. Tipping 
Volume 70, Issue 12, Pages (December 2006)
Glomerular injury is exacerbated in diabetic integrin α1-null mice
Prevention of mesangial sclerosis by bone marrow transplantation
Volume 65, Issue 5, Pages (May 2004)
Volume 56, Issue 5, Pages (November 1999)
Volume 68, Issue 2, Pages (August 2005)
HIV-related nephropathy: A South African perspective
The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H–deficient mice  Jessy J. Alexander, Lee Chaves, Anthony Chang,
Volume 71, Issue 7, Pages (April 2007)
Volume 74, Issue 6, Pages (September 2008)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 89, Issue 4, Pages (April 2016)
Role of the T-cell receptor in kidney ischemia–reperfusion injury
Immunofluorescence on pronase-digested paraffin sections: A valuable salvage technique for renal biopsies  S.H. Nasr, S.J. Galgano, G.S. Markowitz, M.B.
Smad3 Signal Transducer Regulates Skin Inflammation and Specific IgE Response in Murine Model of Atopic Dermatitis  Minna Anthoni, Guoying Wang, Chuxia.
A.K.I. Kuroki, Masayuki Iyoda, Takanori Shibata, Tetsuzo Sugisaki 
The initiation and progression of sickle cell nephropathy
Volume 69, Issue 8, Pages (April 2006)
Mechanisms of tubulointerstitial injury in IgA nephropathy
Fibrosis and renal aging
Volume 74, Issue 9, Pages (November 2008)
Organ transplantation goes to the movies
Donor age intensifies the early immune response after transplantation
Volume 62, Issue 1, Pages (July 2002)
Volume 70, Issue 3, Pages (August 2006)
Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular.
Volume 63, Issue 1, Pages (January 2003)
Amylin deposition in the kidney of patients with diabetic nephropathy
T cells and T-cell receptors in acute renal failure
The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?  Richard E. Gilbert, Mark E. Cooper  Kidney.
Volume 80, Issue 9, Pages (November 2011)
IgA nephropathy: Immune mechanisms beyond IgA mesangial deposition
Volume 78, Issue 3, Pages (August 2010)
Presentation transcript:

Volume 72, Issue 3, Pages 319-327 (August 2007) Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells  H. Suzuki, Y. Suzuki, M. Aizawa, T. Yamanaka, M. Kihara, H. Pang, S. Horikoshi, Y. Tomino  Kidney International  Volume 72, Issue 3, Pages 319-327 (August 2007) DOI: 10.1038/sj.ki.5002300 Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 1 Production of Th1/Th2 cytokines by splenic T cells. (a) Th1- and Th2-prone mice, B6 and BALB, show Th1- and Th2-dominant immune regulation, respectively. Although the levels of IFN-γ and IL-4 remained stable in the quiescent mice from 20 to 40 weeks of age, the onset mice showed significantly higher levels of IFN-γ and lower levels of IL-4 than those of the quiescent mice at 20 and 40 weeks of age (P<0.01). Furthermore, the levels of IFN-γ in the onset mice increased from 20 to 40 weeks of age (P<0.01). (b) To further confirm Th1 polarization in the onset mice, we checked intracellular IFN-γ production in CD4+ T cells by FACS. CD4+ T cells from the onset mice showed higher amounts of intracellular IFN-γ, suggesting strong Th1 polarization. Meanwhile, Th1 polarization is not shown in the quiescent mice; data are mean±s.d. Kidney International 2007 72, 319-327DOI: (10.1038/sj.ki.5002300) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 2 Immunostaining of IgA, IgG, and each IgG subclass in the IgAN-onset ddY mouse. (a) Glomerular IgA deposition was colocalized with IgG. (b) Especially, IgG2a was well colocalized with IgA. Each original magnification is × 400. (c) Glomerular IgA–IgG colocalization was semi-quantitated. Glomerular IgA was well colocalized with IgG2a, followed by IgG1, IgG3, and IgG2b. Data are mean±s.d. Kidney International 2007 72, 319-327DOI: (10.1038/sj.ki.5002300) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 3 Serum levels of IgA/IgG IC. (a) Serum levels of each IgA–IgG IC were expressed by relative value to those of BALB. Serum levels of IgA–IgG2a complex in the IgAN-onset ddY mice (n=30) were significantly higher than those in the quiescent mice (n=30) (P=0.0031). Data are mean±s.d. (b) Serum levels of IgA–IgG2a complex correlated with the severity of glomerular injury (P<0.0001). Kidney International 2007 72, 319-327DOI: (10.1038/sj.ki.5002300) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 4 BMC are responsible for the induction of IgAN. (a–c) Renal pathology. (a) BMT from the onset mice resulted in mesangioproliferative glomerular injury with mesangial deposition of IgA and IgG in the quiescent recipients. (b) BMT from the onset mice accelerated the progression of glomerular injury with IgA and IgG deposition in the onset mice. (c) In contrast, BMT from quiescent mice resulted in reduction of not only glomerular injury but also mesangial deposition of IgA and IgG in the recipient-onset mice. Each original magnification is × 400. (d) Urinary albumin levels. BMT from the onset mice caused progression of albuminuria in the recipient-quiescent mice. BMT from the onset mice caused marked enhancement of albuminuria in the recipient-onset mice. Conversely, levels of albuminuria were decreased in recipient-onset mice after BMT from the quiescent mice. Data are mean±s.d. Kidney International 2007 72, 319-327DOI: (10.1038/sj.ki.5002300) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 5 BMT reconstituted IgAN with Th1 phenotypes. (a) Levels of IFN-γ increased and IL-4 levels decreased in recipient-quiescent mice after BMT from the onset mice (P<0.01). After BMT from the onset mice, IFN-γ levels further increased in recipient-onset mice (P<0.001). Conversely, the splenic productions of IFN-γ decreased and that of IL-4 increased in recipient-onset mice after BMT from the quiescent mice (P<0.01). (b) FACS analysis for the intracellular cytokine production revealed strong IFN-γ expression in CD4+ T cells in the transplanted control mice from the onset mice. (c) Serum levels of IgA–IgG2a IC were expressed relative to those of BALB. BMT from the onset mice to both the quiescent** and the onset mice* resulted in increase in serum IgA–IgG2a complex (*P<0.05 and **P<0.01, respectively), while those levels were decreased after BMT from the quiescent to the onset mice. (d) Serum levels of IgA, IgG, and IgM did not change after each BMT. Data are mean±s.d. Kidney International 2007 72, 319-327DOI: (10.1038/sj.ki.5002300) Copyright © 2007 International Society of Nephrology Terms and Conditions